Bulletin

Our monthly Bulletin highlights the latest work from OHE experts and partners alongside the latest news from across health economics and health care.

Filter results by

Date

Date From

Date To

Filter results by

Date

Date From

Date To

Analysing Global Immunisation Expenditure

Bulletin
April 2025

Improving healthcare resource allocation through better evidence and measurement

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Bulletin
April 2025

HTA and Value-Based Pricing: What Does “Value” Mean?

How Have HTA Agencies Evolved Their Methods Over Time?

Bulletin
March 2025

Addressing health inequality in HTAs

Challanges and Solutions for Budget Impact Analysis of Gene Therapies

Bulletin
March 2025

Turning differences into progress

Bulletin
February 2025

We still care about rare

Establishing the Economic Value of Carbon-Minimal Inhalers

Bulletin
February 2025

Sustainability cannot be a footnote

Infectious disease: another reason to try Veganuary for the NHS

Bulletin
January 2025

2025: all change, please

Bulletin
December 2024

Significant recent achievements in ’24

Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives

Bulletin
December 2024

Human cost of outdated payment models

Is collaboration between and across regulatory and HTA agencies the answer to access challenges?

Bulletin
December 2024

Adapting HTA systems for future needs

Incorporating the Patient Voice in Health Technology Assessment

Bulletin
November 2024

Who gets what? Health economics in action

Bulletin
November 2024

Advance towards better, fairer, healthier societies

Subscribe To Our Newsletter

Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.

News & Insights

Latest Research & Publications

Understanding the Full Value of Long-Acting Therapies: less is more?

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Analysing Global Immunisation Expenditure

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

The Importance of Diversity of Supply in Rare Diseases Markets

2023 OHE Annual Report to the Charity Commission

Employer Costs from Respiratory Infections

All Publications

Bulletin

Filter results by

Filter results by

Improving healthcare resource allocation through better evidence and measurement

HTA and Value-Based Pricing: What Does “Value” Mean?

Addressing health inequality in HTAs

Turning differences into progress

We still care about rare

Sustainability cannot be a footnote

2025: all change, please

Significant recent achievements in ’24

Human cost of outdated payment models

Adapting HTA systems for future needs

Who gets what? Health economics in action

Advance towards better, fairer, healthier societies

Subscribe To Our Newsletter

Share on Mastodon